A former Food and Drug Administration (FDA) official says he’d be "shocked" if the DEA does not reschedule cannabis by next year's presidential election, and that he expects the DEA will ultimately accept the recent Health and Human Services’ recommendation to ease restrictions on cannabis by reclassifying it as a Schedule III drug under the Controlled Substances Act.

“I would be really shocked if it took the DEA longer than the second quarter of next year to come up with its final rule,” said Howard Sklamberg, former …

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.